Showing results (61-70 of 432) with videos related to
Sort By:
Pageof 44
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 18, 2023
Psychedelics: preclinical insights provide directions for future researchRyan H Gumpper, Bryan L RothNature Reviews. Drug Discovery|March 18, 2022
The promises and perils of psychedelic pharmacology for psychiatryTristan D McClure-Begley, Bryan L RothCurrent Protocols in Neuroscience|January 13, 2010
Generation of designer receptors exclusively activated by designer drugs (DREADDs) using directed molecular evolutionYing Pei, Shuyun Dong, Bryan L RothAnnual Review of Medicine|July 28, 2009
The expanded biology of serotoninMiles Berger, John A Gray, Bryan L RothNature Protocols|March 6, 2010
Directed molecular evolution of DREADDs: a generic approach to creating next-generation RASSLsShuyun Dong, Sarah C Rogan, Bryan L RothBiological Research for Nursing|January 26, 2010
Functional SNPs in genes encoding the 5-HT2A receptor modify the affinity and potency of several atypical antipsychotic drugsMarilyn A Davies, Yvette Conley, Bryan L RothCurrent Topics in Medicinal Chemistry|June 8, 2002
Molecular biology of serotonin receptors structure and function at the molecular levelWesley K Kroeze, Kurt Kristiansen, Bryan L RothDrug Discovery Today|July 19, 2006
Screening the receptorome: an efficient approach for drug discovery and target validationRyan T Strachan, Gina Ferrara, Bryan L RothCell|July 29, 2017
How Ligands Illuminate GPCR Molecular PharmacologyDaniel Wacker, Raymond C Stevens, Bryan L RothNature Chemical Biology|October 19, 2017
Discovery of new GPCR ligands to illuminate new biologyBryan L Roth, John J Irwin, Brian K ShoichetPageof 44